Matches in Nanopublications for { ?s ?p "[None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP977310.RAepZ58_Lsl0TgL4xtDvnCztgPm9v6JCYQSOp-W2cuKBQ130_assertion description "[None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977310.RAepZ58_Lsl0TgL4xtDvnCztgPm9v6JCYQSOp-W2cuKBQ130_provenance.
- NP776358.RAcGR41ZgPt7VbWeTcHpRiNqTmN_EzBbFyuU0J6kWNhKs130_assertion description "[None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776358.RAcGR41ZgPt7VbWeTcHpRiNqTmN_EzBbFyuU0J6kWNhKs130_provenance.
- assertion description "[None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP776356.RAruOgW8UKHE_jYYFeAnKuYEGTyjBZnNxReq-bZ7YRELI130_assertion description "[None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776356.RAruOgW8UKHE_jYYFeAnKuYEGTyjBZnNxReq-bZ7YRELI130_provenance.
- NP977294.RAPdAwgvuZ5WDwMvtlxI741VSa5qYbT-8NnVKsmFQ9ER0130_assertion description "[None of the 42 SPRED1-positive individuals (0%; 95% CI, 0%-7%) had discrete cutaneous or plexiform neurofibromas, typical NF1 osseous lesions, or symptomatic optic pathway gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977294.RAPdAwgvuZ5WDwMvtlxI741VSa5qYbT-8NnVKsmFQ9ER0130_provenance.